Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1981 1
1983 2
1985 3
1986 1
1989 1
1990 2
1991 1
1992 1
1993 4
1996 7
1997 9
1998 7
1999 10
2000 9
2001 10
2002 8
2003 16
2004 13
2005 12
2006 13
2007 16
2008 17
2009 33
2010 22
2011 24
2012 29
2013 29
2014 31
2015 47
2016 34
2017 40
2018 41
2019 42
2020 64
2021 79
2022 68
2023 61
2024 29

Text availability

Article attribute

Article type

Publication date

Search Results

736 results

Results by year

Filters applied: . Clear all
Page 1
GLP-1 and Underlying Beneficial Actions in Alzheimer's Disease, Hypertension, and NASH.
Li QX, Gao H, Guo YX, Wang BY, Hua RX, Gao L, Shang HW, Lu X, Xu JD. Li QX, et al. Front Endocrinol (Lausanne). 2021 Sep 6;12:721198. doi: 10.3389/fendo.2021.721198. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34552561 Free PMC article. Review.
However, GLP-1 possesses broader pharmacological effects including anti-inflammation, neuro-protection, regulating blood pressure (BP), and reducing lipotoxicity. These effects are interconnected to the physiological and pathological processes of Alzheimer' …
However, GLP-1 possesses broader pharmacological effects including anti-inflammation, neuro-protection, regulating blood pressure …
Meta-analysis of modifiable risk factors for Alzheimer's disease.
Xu W, Tan L, Wang HF, Jiang T, Tan MS, Tan L, Zhao QF, Li JQ, Wang J, Yu JT. Xu W, et al. J Neurol Neurosurg Psychiatry. 2015 Dec;86(12):1299-306. doi: 10.1136/jnnp-2015-310548. Epub 2015 Aug 20. J Neurol Neurosurg Psychiatry. 2015. PMID: 26294005 Review.
BACKGROUND: The aetiology of Alzheimer's disease (AD) is believed to involve environmental exposure and genetic susceptibility. ...We also found grade I evidence indicative of complex roles of pre-existing disease (frailty, carotid atherosclerosis, …
BACKGROUND: The aetiology of Alzheimer's disease (AD) is believed to involve environmental exposure and genetic suscept …
Hypertension-induced cognitive impairment: from pathophysiology to public health.
Ungvari Z, Toth P, Tarantini S, Prodan CI, Sorond F, Merkely B, Csiszar A. Ungvari Z, et al. Nat Rev Nephrol. 2021 Oct;17(10):639-654. doi: 10.1038/s41581-021-00430-6. Epub 2021 Jun 14. Nat Rev Nephrol. 2021. PMID: 34127835 Free PMC article. Review.
Hypertension affects two-thirds of people aged >60 years and significantly increases the risk of both vascular cognitive impairment and Alzheimer's disease. ...Use of pharmaceutical and lifestyle interventions that reduce blood pressure …
Hypertension affects two-thirds of people aged >60 years and significantly increases the risk of both vascular cognitive impairmen …
Gut Microbiota in Hypertension and Atherosclerosis: A Review.
Verhaar BJH, Prodan A, Nieuwdorp M, Muller M. Verhaar BJH, et al. Nutrients. 2020 Sep 29;12(10):2982. doi: 10.3390/nu12102982. Nutrients. 2020. PMID: 33003455 Free PMC article. Review.
In this review, we discuss how gut microbiota and gut metabolites can affect hypertension and atherosclerosis. Hypertensive patients were shown to have lower alpha diversity, lower abundance of SCFA-producing microbiota, and higher abundance of gram-negative bacteri …
In this review, we discuss how gut microbiota and gut metabolites can affect hypertension and atherosclerosis. Hypertensive pa …
Visit-to-Visit Blood Pressure Variability and Alzheimer's Disease: Links and Risks.
Nagai M, Dote K, Kato M, Sasaki S, Oda N, Kagawa E, Nakano Y, Yamane A, Higashihara T, Miyauchi S, Tsuchiya A. Nagai M, et al. J Alzheimers Dis. 2017;59(2):515-526. doi: 10.3233/JAD-161172. J Alzheimers Dis. 2017. PMID: 28598842 Review.
While hypertension has been shown to be a risk factor for vascular dementia, several studies have also demonstrated that hypertension also increases the risk of Alzheimer's disease (AD). Although the relationship between visit-to-visit blood …
While hypertension has been shown to be a risk factor for vascular dementia, several studies have also demonstrated that hypertens …
Neurovascular and Cognitive Dysfunction in Hypertension.
Iadecola C, Gottesman RF. Iadecola C, et al. Circ Res. 2019 Mar 29;124(7):1025-1044. doi: 10.1161/CIRCRESAHA.118.313260. Circ Res. 2019. PMID: 30920929 Free PMC article. Review.
Long known to be associated with dementia caused by vascular factors, hypertension has more recently been linked also to Alzheimer disease-the major cause of dementia in older people. Thus, although midlife hypertension is a risk factor for late-life d …
Long known to be associated with dementia caused by vascular factors, hypertension has more recently been linked also to Alzheimer …
Magnesium in disease prevention and overall health.
Volpe SL. Volpe SL. Adv Nutr. 2013 May 1;4(3):378S-83S. doi: 10.3945/an.112.003483. Adv Nutr. 2013. PMID: 23674807 Free PMC article. Review.
Magnesium also plays a critical role in nerve transmission, cardiac excitability, neuromuscular conduction, muscular contraction, vasomotor tone, blood pressure, and glucose and insulin metabolism. Because of magnesium's many functions within the body, it plays a ma …
Magnesium also plays a critical role in nerve transmission, cardiac excitability, neuromuscular conduction, muscular contraction, vasomotor …
Blood Pressure and the Risk of Alzheimer's Disease: Is There a Link?
Yuan M, Chen SJ, Li XL, Xu LJ. Yuan M, et al. Am J Alzheimers Dis Other Demen. 2016 Feb;31(1):97-8. doi: 10.1177/1533317515587086. Epub 2015 May 24. Am J Alzheimers Dis Other Demen. 2016. PMID: 26006793 Free PMC article.
Many epidemiologic studies have considered the association between blood pressure and Alzheimer disease, yet the relationship is still controversial. ...Large prospective double-blinded and placebo-controlled studies conducted with the use of standardi …
Many epidemiologic studies have considered the association between blood pressure and Alzheimer disease, yet the …
High Blood Pressure and Risk of Dementia: A Two-Sample Mendelian Randomization Study in the UK Biobank.
Sproviero W, Winchester L, Newby D, Fernandes M, Shi L, Goodday SM, Prats-Uribe A, Alhambra DP, Buckley NJ, Nevado-Holgado AJ. Sproviero W, et al. Biol Psychiatry. 2021 Apr 15;89(8):817-824. doi: 10.1016/j.biopsych.2020.12.015. Epub 2020 Dec 27. Biol Psychiatry. 2021. PMID: 33766239 Free article.
BACKGROUND: Findings from randomized controlled trials have yielded conflicting results on the association between blood pressure (BP) and dementia traits. We tested the hypothesis that a causal relationship exists between systolic BP (SBP) and/or diastolic BP (DBP) …
BACKGROUND: Findings from randomized controlled trials have yielded conflicting results on the association between blood pressure …
Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) study: Rationale, design and baseline characteristics of a randomized control trial of the MIND diet on cognitive decline.
Liu X, Morris MC, Dhana K, Ventrelle J, Johnson K, Bishop L, Hollings CS, Boulin A, Laranjo N, Stubbs BJ, Reilly X, Carey VJ, Wang Y, Furtado JD, Marcovina SM, Tangney C, Aggarwal NT, Arfanakis K, Sacks FM, Barnes LL. Liu X, et al. Contemp Clin Trials. 2021 Mar;102:106270. doi: 10.1016/j.cct.2021.106270. Epub 2021 Jan 9. Contemp Clin Trials. 2021. PMID: 33434704 Free PMC article. Clinical Trial.
Alzheimer's dementia (AD) is the sixth leading cause of death in the U.S., with an estimated $305 billion cost of care in 2020. ...Eligible participants were randomized to either the MIND diet with mild caloric restriction or their usual diet with mild caloric restr …
Alzheimer's dementia (AD) is the sixth leading cause of death in the U.S., with an estimated $305 billion cost of care in 2020 …
736 results